Member Info for Midsummer

I’m not worried by the length of time this FSP is taking.

I was involved in the sale of a small company to a Us firm, and that took 11 months from the day the initial offer thudded onto the door mat, until the old management-team closed the door quietly behind them and headed into the sunset.

I can only imagine the complexities of weeding out and negotiating multiple offers in a slightly dodgy juro in the middle of a global pandemic for a company whose assets are not 100% identified.

No , not worried at all. Good things come to those that wait.

3 green boxes in a row. I can guess who.
But tbh I’m thinking about filtering anyone who keeps feeding them.
This really is the worst I can remember the board in the last year. It’s really quite unbearable.

Sally, brilliant post and the reason I topped on Thursday ( wish I had waited til Friday!)

Ian, thank you for your wonderful uplifting post. You have a wonderful way with words. Wishing you a lovely day with fond memories of your mother.

Cannot buy any at this price on HL, not even £500

252,000 golden tickets.

A thank you to Trek from me as well, I got into this share after reading your posts.
Your informed posts back on GDR last year marked you out as a rare breed.
I definitely owe you a drink or three....thanks again for sharing your research and knowledge.

Value finder... can you expand on your comment and reason behind it?

The chairman has handled at least two sales before... Axis Shield and one just recently.

The aim of the board is about maximising shareholder value... therefore if an amazing offer comes up they will be duty bound to consider it.

@Bovey , can’t buy anything on HL either, not even £500

@weedavemac... May be best to call HL.. I had requested they vote and asked for confirmation on Weds 28 th. Phoned HL this afternoon to follow up and got a confirmation through this evening . I have no idea if my first email was read or not so recommend you follow up.

Votes cast with HL.
1.2 million shares

I set up a stop loss yesterday at 22.5p as I have a large % of my of invested here.
I have never used SL before and the ******** got taken out on over three quarters of my shares. Can’t believe the timing of it!!
But I’ll be buying back in tomorrow. Unless there’s an RNS to the contrary.

These new brand of investors are so tedious... either posting old RNS, or a running commentary of the share price hourly movements. Waste of space.

Sorry if this is a naive question... Only been investing for a relatively short period of time and been here since 20p March days.

Just wondered what people think is the future here? If the company does not capitalise on its Covid test, is it likely to be bought out by another company for its portfolio of other products and IP?

Or will it have a future standing alone selling its other products and developing new ones?

Or is it likely that the deal with Beckman is chugging away in the background and that is why there is little news or sales figures being generated until it’s signed? Maybe FDA approval is needed before Beckman will finalise the deal?

The long game I believe is that testing is here forever, given the mutations we have seen already in such a short space of time. How many more mutations have happened/ will happen elsewhere in the world?
Just musings because I’m starting to lose the faith.

Radiagreen, do you have any evidence that the South African strain definitely is immune to the vaccine?

If the deadline for offers is 18 Jan and the final bid isn’t received until that, I wonder how long it will take for the buyer to be announced after that?

Southstand, not sure I agree with your analysis there.
If the company has 10 m stock and gets a loan from the bank for half, then the company has 10m stock, 5m cash from the bank and 5m loan from the bank. Net assets are still 10m .

Tilley, just love your turn of phrase... chocolate coins ha ha!
After the deal is done I shall miss the unique camaraderie on this board.
Wishing you all a very healthy, wealthy and Happy New Year.

Bombay, thank you, I see exactly what you mean.

Bombay, I agree with you totally and your view on the auditors likely opinion...used to be called substance over form in my day.

Wolf you are right, if it was to be treated as a sale to Syme there would be the vat funding issue too.

However I just can’t see the transfer of the stock to Syme being treated as a sale , as it would have to be repurchased when the stock is sold to the end customer. To do this you would be recording 2 sales transactions and two purchase transactions.
It has to be as NS20 said which is the stock stays on the balance sheet, the cash is received from Syme and a corresponding credit balance is created until the sale to the third party. At that point a sale is triggered, vat liability triggered. Then when the customer pays then SYME credit can be repaid. Plus the transaction charge.

All IMO and would be delighted to hear from anyone more au fair with the latest FRS.